Glycemic control determines hepatic and peripheral glucose effectiveness in type 2 diabetic subjects

Diabetes

Volumn 51, Issue 7, 2002, Pages 2179-2189

  Hawkins, Meredith ^a   Gabriely, Ilan ^a   Wozniak, Robert ^a   Reddy, Kalpana ^a   Rossetti, Luciano ^a   Shamoon, Harry ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN;

ADULT; ARTICLE; CHRONICITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE UTILIZATION; HUMAN; LIVER METABOLISM; MALE; MUSCLE METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

EID: 0036307329     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.51.7.2179     Document Type: Article

References (56)

1. The triumvirate: Beta cell, muscle and liver: A collusion responsible for NIDDM
2. Relationship between insulin secretion, insulin action and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects
3. Hepatic and peripheral insulin resistance: A common feature of type 2 (non-insulin-dependent) and type 1 (insulin-dependent) diabetes mellitus
4. Quantification of the relative impairment in actions of insulin on hepatic glucose production and peripheral glucose uptake in non-insulin-dependent diabetes mellitus
5. Glucose effectiveness assessed under dynamic and steady state conditions
6. Regulation of endogenous glucose production by glucose per se is impaired in type 2 diabetes mellitus
7. Contribution of abnormal muscle and liver glucose metabolism to postprandial hypergycemia in NIDDM
8. Autoregulation of hepatic glucose production
9. Glucose-6-phosphatase flux in vitro is increased in type 2 diabetes
10. Hyperglycemia contributes insulin resistance in hepatic and adipose tissue but not skeletal muscle of ZDF rats
11. Phlorizin treatment of diabetic rats partially reverses the abnormal expression of genes involved in hepatic glucose metabolism
12. Stimulation of glucose-6-phosphatase gene expression by glucose and fructose-2,6-bisphosphate
13. Glucose regulates in vivo glucose-6-phosphatase gene expression in the liver of diabetic rats
14. Induction of hepatic glucose-6-phosphatase gene expression by lipid infusion
15. Role of AMP-activated protein kinase in mechanism of metformin action
16. Mechanisms involved in the coordinate regulation of strategic enzymes of glucose metabolism
17. Clinical pharmacokinetics of troglitazone
18. Meta-analysis of steady-state pharmacokinetics of troglitazone and its metabolites
19. Increased epinephrine and skeletal muscle responses to hypoglycemia in noninsulin-dependent diabetes mellitus
20. Effect of overnight restoration of overnight euglycemia on glucose effectiveness in type 2 diabetes mellitus
21. Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamp: Comparison of unlabeled and labeled glucose infusates
22. 14C) labels
23. Regulation of counterregulatory hormone secretion in man during exercise and hypoglycemia
24. D-lactate
25. The Kjeldahl method
26. Influences of glucose loading and of injected insulin on hepatic glucose output
27. Relative contribution of glycogen synthesis and glycolysis to insulin-mediated glucose uptake: A dose-response euglycemic clamp study in normal and diabetic rats
28. Quantitation of glycolysis and skeletal muscle glycogen synthesis in humans
29. Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: Contribution of excessive hepatic glucose production and impaired tissue glucose uptake
30. Lessons from the Diabetes Control and Complications Trial
31. Endogenous glucose production and glucose effectiveness in type 2 diabetic subjects derived from stable-labeled minimal model approach
32. Normal glucose-induced suppression of glucose production but impaired stimulation of glucose disposal in type 2 diabetes
33. Liver glucokinase: Decreased activity in patients with type II diabetes
34. Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus
35. Impaired hepatic glycogen synthesis in glucokinase-deficient (MODY-2) subjects
36. Abnormal regulation of HGP by hyperglycemia in mice with a disrupted glucokinase allele
37. Glucosamine-induced inhibition of liver glucokinase impairs the ability of hyperglycemia to suppress endogenous glucose production
38. Carbon flux via the pentose phosphate pathway regulates the hepatic expression of the glucose-6-phosphatase and phosphoenolpyruvate carboxykinase genes in conscious rats
39. Free fatty acids and pathogenesis of type 2 diabetes mellitus
40. The role of fatty acids in mediating the effects of peripheral insulin on hepatic glucose production in the conscious dog
41. Fatty acids mediate the acute extrahepatic effects of insulin on hepatic glucose production in humans
42. Mechanisms of fatty acids induced inhibition of glucose uptake
43. Inhibition of lipolysis decreases lipid oxidation and gluconeogenesis from lactate but not fasting hyperglycemia or total hepatic glucose production in NIDDM
44. The effects of free fatty acids on gluconeogenesis and glycogenolysis in normal subjects
45. Mechanisms of liver and muscle insulin resistance induced by chronic high-fat feeding
46. Role of glucose effectiveness in the determination of glucose tolerance
47. Effects of lactate infusion on hepatic gluconeogenesis and glycogenolysis
48. Rates and tissue sites of non-insulin- and insulin-mediated glucose uptake in humans
49. Kinetics of insulin-mediated and non-insulin-mediated glucose uptake in humans
50. Studies on the mass action effect of glucose in NIDDM and IDDM: Evidence for glucose resistance
51. Alterations in non-insulin-mediated glucose uptake in the elderly patient with diabetes
52. Hyperglycemia activates glucose transport in rat skeletal muscle via a Ca(2+)-dependent mechanism
53. In L6 skeletal muscle cells, glucose induces cytosolic translocation of protein kinase C-α and trans-activates the insulin receptor kinase
54. Assessment of hepatic insulin action in obese type 2 diabetic patients
55. Effects of insulin on glucose turnover rates in vivo: Isotope dilution versus constant specific activity technique